Login / Signup

The Removal of HBV in Plasma by Extracorporeal Immunoadsorption from Plasma: A Potential Therapy of Hepatitis B Patients.

Zhenwei HanXuan LuYiping TangYuanyuan YangQiuchen LiuPengfei ChengLi ZhouYefu Wang
Published in: BioMed research international (2018)
All these results indicated that the novel immunoadsorbent could effectively remove HBV particles and likely serve as a novel therapy option or at least supplementary for the treatment regimen of HBV.
Keyphrases
  • hepatitis b virus
  • liver failure
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • risk assessment
  • mesenchymal stem cells
  • bone marrow
  • climate change